These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 1115398)

  • 1. The electrophysiology of Norpace (Part II).
    Befeler B
    Angiology; 1975 Jan; 26(1 Pt 2):116-9. PubMed ID: 1115398
    [No Abstract]   [Full Text] [Related]  

  • 2. The electrophysiology of Norpace (Part III).
    Caracta A
    Angiology; 1975 Jan; 26(1 Pt 2):120-3. PubMed ID: 1115399
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacology of Norpace.
    Dean RR
    Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403
    [No Abstract]   [Full Text] [Related]  

  • 4. The electrophysiology of Norpace (Part I).
    Dreifus LS
    Angiology; 1975 Jan; 26(1 Pt 2):111-5. PubMed ID: 1115397
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical studies of Norpace. Summarizing remarks.
    Fowler NO
    Angiology; 1975 Jan; 26(1 Pt 2):154-5. PubMed ID: 1090216
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical studies of Norpace (Part IX).
    Oshrain C
    Angiology; 1975 Jan; 26(1 Pt 2):146-7. PubMed ID: 123135
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac effects of disopyramide.
    Danilo P; Rosen MR
    Am Heart J; 1976 Oct; 92(4):532-6. PubMed ID: 785992
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical studies of Norpace (Part XI).
    Nisbet T
    Angiology; 1975 Jan; 26(1 Pt 2):149-53. PubMed ID: 46729
    [No Abstract]   [Full Text] [Related]  

  • 9. Electrophysiological evaluation of disopyramide in man.
    Josephson ME; Caracta AR; Lau SH; Gallagher JJ; Damato AN
    Am Heart J; 1973 Dec; 86(6):771-80. PubMed ID: 4757788
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse effects of disopyramide (Norpace): toxic interactions with other antiarrhythmic agents.
    Ellrodt G; Singh BN
    Heart Lung; 1980; 9(3):469-74. PubMed ID: 6901519
    [No Abstract]   [Full Text] [Related]  

  • 11. The hemodynamic effects of Norpace. (Part II).
    Willis PW
    Angiology; 1975 Jan; 26(1 Pt 2):102-10. PubMed ID: 1115396
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical pharmacology of the antiarrhythmic agent disopyramide phosphate (Norpace).
    Befeler B; Lazzara R
    Heart Lung; 1980; 9(3):475-82. PubMed ID: 6901520
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical studies of Norpace (Part III).
    Kalmansohn RG
    Angiology; 1975 Jan; 26(1 Pt 2):137. PubMed ID: 1115400
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical studies of Norpace (Part II).
    Vismara L
    Angiology; 1975 Jan; 26(1 Pt 2):132-6. PubMed ID: 1090213
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical studies of Norpace (Part VII).
    Berman R
    Angiology; 1975 Jan; 26(1 Pt 2):143. PubMed ID: 1090214
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic basis for the treatment of cardiac arrhythmias.
    Gelband H; Rosen MR
    Pediatrics; 1975 Jan; 55(1):59-67. PubMed ID: 1089243
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical studies of Norpace (Part V).
    Cook WR
    Angiology; 1975 Jan; 26(1 Pt 2):140-1. PubMed ID: 1115401
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical studies of Norpace (Part X).
    Dreifus LS
    Angiology; 1975 Jan; 26(1 Pt 2):148. PubMed ID: 46728
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological treatment of arrhythmia].
    Kuch J
    Pol Tyg Lek; 1983 Jan; 38(3):103-8. PubMed ID: 6135199
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of anti-arrhythmia drugs on the heart conduction system].
    Walczak F
    Kardiol Pol; 1992; 36(2):92-6. PubMed ID: 1583832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.